Buckingham analyst Megan McGrath raised her price target for Hovnanian to $27 from $24 based on "solid" Q4 results and higher FY20 earnings expectations. McGrath tells investors in a research note that she expects the company's near-term focus to remain on growing its community count and revenue base rather than debt reduction. The analyst maintains a Neutral rating, saying she sees near-term risk in slowing growth, as these easy comps ease in mid-2020 and as Hovnanian's ability to continue to grow community count could be challenged as it delivers on the strong 2019 orders.